Lenny Bernstein covered the increased need for volunteers to test new drugs for The Washington Post To Your Health blog this week. He writes:
The number of people who are appropriate research subjects and willing to spend the time, unpaid, to test new therapies has declined sharply even as trials have become more complex and the Food and Drug Administration, among others, has demanded more data. More than 10 percent of trials in a sample taken in 2011 failed because researchers were unable to recruit even a single test subject.
And if it's that hard to find one subject, recruiting thousands can seem almost insurmountable:
Lipitor, which is used to treat high cholesterol, was tested on 20,000 people over 2 1/2 years, according to CISCRP [Center for Information and Study on Clinical Research Participation]. The allergy medication Allegra was in clinical trials for two years and tested on 3,600 people.
Read Bernstein's full article.
Register now for Fox Trial Finder to be matched with Parkinson's clinical studies that need volunteers, both those with PD and without.